Edgewise Therapeutics: Top Small Cap Buy

This is a news story, published by Yahoo Finance, that relates primarily to Debjit Chattopadhyay news.

Debjit Chattopadhyay news

For more Debjit Chattopadhyay news, you can click here:

more Debjit Chattopadhyay news

stocks trading & speculation news

For more stocks trading & speculation news, you can click here:

more stocks trading & speculation news

Yahoo Finance news

For more news from Yahoo Finance, you can click here:

more news from Yahoo Finance

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about

other top small cap stocks

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Small Cap Stocks news, Cap Stocks news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

top small cap stocks

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

•

Business

Business & Economics

Is Edgewise Therapeutics, Inc. (EWTX) the Best Small Cap Stock to Buy with the Biggest Upside Potential?

Summary

Nutrition label

84% Informative

Edgewise Therapeutics, Inc. (NASDAQ: EWTX ) is a clinical-stage biopharmaceutical company that develops, discovers, commercializes and commercializes innovative treatments for rare muscle disorders.

The list of top small cap stocks to buy with biggest upside potential is presented in ascending order of stocks’ upside potential.

Guggenheim analyst Debjit Chattopadhyay initiated coverage of Edgewise Therapeutics, Inc. (NASDAQ: EWTX ) with a Buy rating on April 30 , setting a $ 41 price target.

EWTX ranks 7th on our list of top small-cap stocks to buy with biggest upside potential.

VR Score

Informative language

Neutral language

Article tone

semi-formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech